For the Inventor, By the Inventor

Enter assignee name

Calgary, Canada

Wyvern Pharmaceuticals Inc.

USPTO Granted Patents = 103

Forward Citations = 45

Loading Chart...

Loading Chart...

4 inventors (with patents filed for the assignee):

Bradley G Thompson (102 out of 151 patents)

Jill L Thompson (10 out of 10 patents)

Jillian Thompson (2 out of 2 patents)

4. Bradley G Thompson (1 out of 1 patent)

Core Competencies:

RNA

Plasmid

Fusion Protein

Interfering RNA

Antibody Production

Protein Regulation

DNAse-I

TLR9

103 patents: Sort by Forward Citations

1. 12729380 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-09-08),

2. 12729379 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-09-08),

3. 12716068 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-08-25),

4. 12680103 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-07-14),

5. 12644124 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-06-02),

6. 12618075 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-05-05),

7. 12618073 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-05-05),

8. 12595484 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-04-07),

9. 12584134 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-24),

10. 12584129 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-24),

11. 12570983 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-10),

12. 12570979 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-10),

13. 12565657 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-03),

14. 12565655 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-03),

15. 12565652 - COMPOSITION FOR REGULATING PRODUCTION OF INTERFERING RIBONUCLEIC ACID (2026-03-03),

Company Overview

Wyvern Pharmaceuticals Inc., based in Calgary, Canada, specializes in the field of RNA regulation, focusing on innovative therapeutic solutions. The company is dedicated to advancing the understanding and application of RNA technologies, including plasmids, fusion proteins, and interfering RNA. Their research encompasses critical areas such as antibody production, protein regulation, and the utilization of DNAse-I and TLR9 pathways, positioning them at the forefront of biopharmaceutical development aimed at addressing complex medical challenges.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

103 Patents

#8 in Calgary

#118 in Canada

#7,583 in the World

Calgary, Canada

Wyvern Pharmaceuticals Inc.

Forward Citations = 45

4 inventors:

Bradley G Thompson (102 out of 151 patents)

Jill L Thompson (10 out of 10 patents)

Jillian Thompson (2 out of 2 patents)

4. Bradley G Thompson (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Wyvern Pharmaceuticals Inc.. Retrieved from https://idiyas.com/company/wyvern-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…